The role of the CPNKEKEC sequence in the beta(2) subunit I domain in regulation of integrin alpha(L)beta(2) (LFA-1) - PubMed (original) (raw)

. 2002 Mar 1;168(5):2296-301.

doi: 10.4049/jimmunol.168.5.2296.

Affiliations

• PMID: 11859118
• DOI: 10.4049/jimmunol.168.5.2296

Free article

The role of the CPNKEKEC sequence in the beta(2) subunit I domain in regulation of integrin alpha(L)beta(2) (LFA-1)

Tetsuji Kamata et al. J Immunol. 2002.

Free article

Abstract

The alpha(L) I (inserted or interactive) domain of integrin alpha(L)beta(2) undergoes conformational changes upon activation. Recent studies show that the isolated, activated alpha(L) I domain is sufficient for strong ligand binding, suggesting the beta(2) subunit to be only indirectly involved. It has been unclear whether the activity of the alpha(L) I domain is regulated by the beta(2) subunit. In this study, we demonstrate that swapping the disulfide-linked CPNKEKEC sequence (residues 169-176) in the beta(2) I domain with a corresponding beta(3) sequence, or mutating Lys(174) to Thr, constitutively activates alpha(L)beta(2) binding to ICAM-1. These mutants do not require Mn(2+) for ICAM-1 binding and are insensitive to the inhibitory effect of Ca(2+). We have also localized a component of the mAb 24 epitope (a reporter of beta(2) integrin activation) in the CPNKEKEC sequence. Glu(173) and Glu(175) of the beta(2) I domain are identified as critical for mAb 24 binding. Because the epitope is highly expressed upon beta(2) integrin activation, it is likely that the CPNKEKEC sequence is exposed or undergoes conformational changes upon activation. Deletion of the alpha(L) I domain did not eliminate the mAb 24 epitope. This confirms that the alpha(L) I domain is not critical for mAb 24 binding, and indicates that mAb 24 detects a change expressed in part in the beta(2) subunit I domain. These results suggest that the CPNKEKEC sequence of the beta(2) I domain is involved in regulating the alpha(L) I domain.

PubMed Disclaimer

Similar articles

• Effects of I domain deletion on the function of the beta2 integrin lymphocyte function-associated antigen-1.
  Leitinger B, Hogg N. Leitinger B, et al. Mol Biol Cell. 2000 Feb;11(2):677-90. doi: 10.1091/mbc.11.2.677. Mol Biol Cell. 2000. PMID: 10679023 Free PMC article.
• Epitope mapping of antibodies to the C-terminal region of the integrin beta 2 subunit reveals regions that become exposed upon receptor activation.
  Lu C, Ferzly M, Takagi J, Springer TA. Lu C, et al. J Immunol. 2001 May 1;166(9):5629-37. doi: 10.4049/jimmunol.166.9.5629. J Immunol. 2001. PMID: 11313403
• The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain.
  Fraemohs L, Koenen RR, Ostermann G, Heinemann B, Weber C. Fraemohs L, et al. J Immunol. 2004 Nov 15;173(10):6259-64. doi: 10.4049/jimmunol.173.10.6259. J Immunol. 2004. PMID: 15528364
• The role of the cysteine-rich region of the beta2 integrin subunit in the leukocyte function-associated antigen-1 (LFA-1, alphaLbeta2, CD11a/CD18) heterodimer formation and ligand binding.
  Douglass WA, Hyland RH, Buckley CD, Al-Shamkhani A, Shaw JM, Scarth SL, Simmons DL, Law SK. Douglass WA, et al. FEBS Lett. 1998 Dec 4;440(3):414-8. doi: 10.1016/s0014-5793(98)01498-7. FEBS Lett. 1998. PMID: 9872413
• Therapeutic antagonists and the conformational regulation of the beta2 integrins.
  Shimaoka M, Springer TA. Shimaoka M, et al. Curr Top Med Chem. 2004;4(14):1485-95. doi: 10.2174/1568026043387575. Curr Top Med Chem. 2004. PMID: 15544539 Review.

Cited by

• Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions.
  Yang W, Shimaoka M, Chen J, Springer TA. Yang W, et al. Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2333-8. doi: 10.1073/pnas.0307291101. Proc Natl Acad Sci U S A. 2004. PMID: 14983010 Free PMC article.
• The insider's guide to leukocyte integrin signalling and function.
  Hogg N, Patzak I, Willenbrock F. Hogg N, et al. Nat Rev Immunol. 2011 Jun;11(6):416-26. doi: 10.1038/nri2986. Epub 2011 May 20. Nat Rev Immunol. 2011. PMID: 21597477 Review.
• Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes.
  Anikeeva N, Somersalo K, Sims TN, Thomas VK, Dustin ML, Sykulev Y. Anikeeva N, et al. Proc Natl Acad Sci U S A. 2005 May 3;102(18):6437-42. doi: 10.1073/pnas.0502467102. Epub 2005 Apr 25. Proc Natl Acad Sci U S A. 2005. PMID: 15851656 Free PMC article.
• Structure of an integrin with an alphaI domain, complement receptor type 4.
  Xie C, Zhu J, Chen X, Mi L, Nishida N, Springer TA. Xie C, et al. EMBO J. 2010 Feb 3;29(3):666-79. doi: 10.1038/emboj.2009.367. Epub 2009 Dec 24. EMBO J. 2010. PMID: 20033057 Free PMC article.
• Variation in one residue associated with the metal ion-dependent adhesion site regulates αIIbβ3 integrin ligand binding affinity.
  Raborn J, Fu T, Wu X, Xiu Z, Li G, Luo BH. Raborn J, et al. PLoS One. 2013 Oct 8;8(10):e76793. doi: 10.1371/journal.pone.0076793. eCollection 2013. PLoS One. 2013. PMID: 24116162 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal